← Eichor
Study identifier: NCT06839950 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Sensory Profile and Early Clinical Signs of Calm Room Users

Condition: Psychotic Disorders · Personality Disorders · Mood Disorders  ·  Sponsor: Centre Hospitalier Esquirol

PhaseN/A
Planned participants80
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This descriptive study aims primarily to characterize the sensory profile of patients in a closed psychiatric hospital unit who use a calming room. The main questions it aims to answer are : * Could sensory information processing disorders be the cause of distress and tension in these patients? * Could users of the calming room present extreme sensory processing profiles, characterized by either hypersensitivity or hyposensitivity ? Participants will answer a survey to determine their the sensory profile. Participants can already use the calming room as part of their regular medical care and they will answer surveys before and after each use.

This description comes directly from the study's public registry record.

Talk to the study team

Aude Paquet, PhD in Psychology  ·  +33 5-55-43-11-27  ·  aude.paquet@ch-esquirol-limoges.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Esquirol Hsopital CenterLimoges, New Aquitaine, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06839950